Local Control in Thoracic Stereotactic Ablative Radiation Therapy: Analysis of Motion Management and Single-Fraction Dosimetry From the iSABR Trial
International Journal of Radiation Oncology*Biology*Physics · 2025
DOI: 10.1016/j.ijrobp.2025.12.017 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2025. Verfasst von Joseph Abi Jaoude und 23 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Stanford University, Stanford, California. Electronic address: joeyaj98@stanford.edu. Hauptthemen laut MEDLINE: Radiosurgery, Lung Neoplasms, Neoplasm Recurrence, Local, Respiration. Die Arbeit nennt 28 Literaturangaben. Gefördert von: AstraZeneca, Varian Medical Systems, Radiological Society of North America.
Abstract (Originalsprache)
PURPOSE: Thoracic stereotactic ablative radiation therapy (SABR) is an effective treatment for lung tumors. We evaluated the association between tumor control and (a) tumor respiratory motion and motion management approach and (b) single-fraction dose metrics in patients treated on a prospective clinical trial. METHODS AND MATERIALS: We evaluated 235 patients with 277 thoracic tumors treated on the iSABR trial. Motion management approaches included motion inclusive (MI, 41%), MI with extreme breaths excluded (13%), expiratory gating (Exp Gating, 24%), and inspiratory breath hold (IBH, 22%). The association between tumor motion, motion management technique, and local recurrence (LR) was evaluated using Fine-Gray Analysis. Among the cohort of patients treated in a single fraction (150 tumors), we performed a tumor control probability analysis for dose to the gross tumor (GTV) and planning treatment volumes. RESULTS: There was no significant difference in LR by tumor motion when dichotomized to 29.4 Gy and a GTV D95% > 28.1 Gy. CONCLUSIONS: These findings suggest that motion management techniques including Exp Gating and IBH can adequately control respiratory motion. Furthermore, single-fraction SABR with 25 Gy resulted in high rates of LC for small tumors when using heterogeneous dosimetry, including 29.4 Gy to 68.3% of the GTV and 28.1 Gy to 95% of the GTV.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Radiation Oncology, Stanford University, Stanford, California. Electronic address: joeyaj98@stanford.edu.
- Department of Radiation Oncology, University of Washington, Seattle, Washington.
- Department of Radiation Oncology, Stanford University, Stanford, California.
- Department of Radiation Oncology, Hokkaido University, Hokkaido, Japan.
- Department of Radiation Oncology, Westmead Hospital, Sydney, Australia; University of Sydney, Sydney, Australia.
- Department of Radiation Medicine and Applied Sciences, University of California San Diego School of Medicine, La Jolla, California.
Förderung
- AstraZeneca
- Varian Medical Systems
- Radiological Society of North America
- Hokkaido University
- Sylvia and Charles Viertel Charitable Foundation
- American Society for Radiation Oncology
Zitieren
APA
Abi Jaoude, J., Cui, S., Fu, J., Worth, J. E., Campbell, M. J., Lau, B., Eswarappa, S., Richter, S. A., Meurice, N., Shirato, H., Taguchi, H., Gee, H., Romero, I. O., Dubrowski, P., Pham, D., Skinner, L., Butler, S. S., Kastelowitz, N., Chin, A. L., …, & Vitzthum, L. K. (2025). Local Control in Thoracic Stereotactic Ablative Radiation Therapy: Analysis of Motion Management and Single-Fraction Dosimetry From the iSABR Trial. International Journal of Radiation Oncology*Biology*Physics. https://doi.org/10.1016/j.ijrobp.2025.12.017
Vancouver
Abi Jaoude J, Cui S, Fu J, Worth JE, Campbell MJ, Lau B, et al. Local Control in Thoracic Stereotactic Ablative Radiation Therapy: Analysis of Motion Management and Single-Fraction Dosimetry From the iSABR Trial. International Journal of Radiation Oncology*Biology*Physics. 2025. doi:10.1016/j.ijrobp.2025.12.017
BibTeX
@article{AbiJaoude2025,
author = {Abi Jaoude, Joseph and Cui, Sunan and Fu, Jie and Worth, John Emmett and Campbell, Matthew John and Lau, Brianna and Eswarappa, Shaila and Richter, Sara A and Meurice, Naomi and Shirato, Hiroki and Taguchi, Hiroshi and Gee, Harriet and Romero, Ignacio Omar and Dubrowski, Piotr and Pham, Daniel and Skinner, Lawrie and Butler, Santino S and Kastelowitz, Noah and Chin, Alexander L and Gensheimer, Michael F and Diehn, Maximilian and Loo, Billy W and Moiseenko, Vitali and Vitzthum, Lucas Kas},
title = {Local Control in Thoracic Stereotactic Ablative Radiation Therapy: Analysis of Motion Management and Single-Fraction Dosimetry From the iSABR Trial},
journal = {International Journal of Radiation Oncology*Biology*Physics},
year = {2025},
doi = {10.1016/j.ijrobp.2025.12.017}
}
EUVIMED